|
1
|
Yang Y, Zhang M and Zhuang Z: Causes
investigation of uveitis recurrence. Medical J Peking Union Med
College Hospital. 4:150–153. 2013.(In Chinese).
|
|
2
|
Xu X and Jiahua Lv: Observation of T
lymphocyte change of rat with autoimmunity uveitis. Chinese
Ophthalmic Res. 26:841–844. 2008.(In Chinese).
|
|
3
|
Trinh L, Brignole-Baudouin F, Pauly A,
Liang H, Houssier M and Baudouin C: Th1- and Th2-related chemokine
and chemokine receptor expression on the ocular surface in
endotoxin-induced uveitis. Mol Vis. 14:2428–2434. 2008.PubMed/NCBI
|
|
4
|
Thibault DL, Chu AD, Graham KL, Balboni I,
Lee LY, Kohlmoos C, Landrigan A, Higgins JP, Tibshirani R and Utz
PJ: IRF9 and STAT1 are required for IgG autoantibody production and
B cell expression of TLR7 in mice. J Clin Invest. 118:1417–1426.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sun S, Rao NL, Venable J, Thurmond R and
Karlsson L: TLR7/9 antagonists as therapeutics for immune-mediated
inflammatory disorders. Inflamm Allergy Drug Targets. 6:223–235.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Takase H, Yu CR, Ham DI, Chan CC, Chen J,
Vistica BP, Wawrousek EF, Durum SK, Egwuagu CE and Gery I:
Inflammatory processes triggered by TCR engagement or by local
cytokine expression: differences in profiles of gene expression and
infiltrating cell populations. J Leukoc Biol. 80:538–545. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wu W: Observation and analysis of
glucocorticoid treatment on uveitis in clinical effect. World
Latest Medicine Information. 15:94–97. 2015.
|
|
8
|
Jabs DA, Nussenblatt RB and Rosenbaum JT:
Standardization of Uveitis Nomenclature (SUN) Working Group:
Standardization of uveitis nomenclature for reporting clinical
data. Results of the First International Workshop. Am J Ophthalmol.
140:509–516. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sugita S, Kawazoe Y, Imai A, Yamada Y,
Horie S and Mochizuki M: Inhibition of Th17 differentiation by
anti-TNF-alpha therapy in uveitis patients with Behçet's disease.
Arthritis Res Ther. 14:R992012. View
Article : Google Scholar : PubMed/NCBI
|
|
10
|
Allensworth JJ, Planck SR, Rosenbaum JT
and Rosenzweig HL: Investigation of the differential potentials of
TLR agonists to elicit uveitis in mice. J Leukoc Biol.
90:1159–1166. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chinnery HR, Leong CM, Chen W, Forrester
JV and McMenamin PG: TLR9 and TLR7/8 activation induces formation
of keratic precipitates and giant macrophages in the mouse cornea.
J Leukoc Biol. 97:103–110. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu Z and Liu J: Research summary of
related-uveitis cytokines. Heilongjiang Med J. 40:8–9. 2016.(In
Chinese).
|
|
13
|
Sun R, Sun L, Bao M, Zhang Y and Wang L,
Wu X, Hu D, Liu Y, Yu Y and Wang L: A human microsatellite
DNA-mimicking oligodeoxynucleotide with CCT repeats negatively
regulates TLR7/9-mediated innate immune responses via selected TLR
pathways. Clin Immunol. 134:262–276. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sacco RE, Nicholson TL, Waters TE and
Brockmeier SL: Porcine TLR3 characterization and expression in
response to influenza virus and Bordetella bronchiseptica. Vet
Immunol Immunopathol. 142:57–63. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Beutler BA: TLRs and innate immunity.
Blood. 113:1399–1407. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hsu LC, Park JM, Zhang K, Luo JL, Maeda S,
Kaufman RJ, Eckmann L, Guiney DG and Karin M: The protein kinase
PKR is required for macrophage apoptosis after activation of
Toll-like receptor 4. Nature. 428:341–345. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Krieg AM and Vollmer J: Toll-like
receptors 7, 8, and 9: linking innate immunity to autoimmunity.
Immunol Rev. 220:251–269. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Prinz M, Garbe F, Schmidt H, Mildner A,
Gutcher I, Wolter K, Piesche M, Schroers R, Weiss E, Kirschning CJ,
et al: Innate immunity mediated by TLR9 modulates pathogenicity in
an animal model of multiple sclerosis. J Clin Invest. 116:456–464.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Forsbach A, Nemorin JG, Völp K, Samulowitz
U, Montino C, Müller C, Tluk S, Hamm S, Bauer S, Lipford GB, et al:
Characterization of conserved viral leader RNA sequences that
stimulate innate immunity through TLRs. Oligonucleotides.
17:405–417. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hasimu A, Ge L, Li QZ, Zhang RP and Guo X:
Expressions of Toll-like receptors 3, 4, 7, and 9 in cervical
lesions and their correlation with HPV16 infection in Uighur women.
Chin J Cancer. 30:344–350. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
De Trez C, Pajak B, Brait M, Glaichenhaus
N, Urbain J, Moser M, Lauvau G and Muraille E: TLR4 and Toll-IL-1
receptor domain-containing adapter-inducing IFN-beta, but not
MyD88, regulate Escherichia coli-induced dendritic cell maturation
and apoptosis in vivo. J Immunol. 175:839–846. 2005. View Article : Google Scholar : PubMed/NCBI
|
